CUV 1.34% $14.79 clinuvel pharmaceuticals limited

Ann: Update - Notification of buy-back - CUV, page-6

  1. 458 Posts.
    lightbulb Created with Sketch. 240
    Vitiligo trial is almost six months in. If you were to go by Clinuvel announcements and the clinical trials website they've dosed one patient in one centre. I know they've said they don't want a regular run rate being published but surely an update on progress this month would be reasonable?! In absence of this people begin to think the worst.
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.